🤖 Search 5,000+ AI tools Ask our bot for help →

Discover the latest tools and trends in AI 🔮

Join 50,000+ subscribers including Amazon, Apple, Google, and Microsoft employees reading our free newsletter.

[email protected] Subscribe

Nucleai nabs $14M for AI healthcare expansion

Nucleai nabs $14M for AI healthcare expansion
Nucleai nabs $14M for AI healthcare expansion

Nucleai, a spatial AI biomarker startup based in Chicago, IL and Tel Aviv, Israel, raised $14M in funding.

M Ventures led the round, with existing investors also participating. The funds will be used to accelerate the deployment of Nucleai's spatial analysis technology.

Led by CEO Avi Veidman, Nucleai leverages geospatial analytical methods to analyze tissue samples, aiding in the development of bi-specifics, antibody-drug conjugates (ADCs), and immunotherapy. The platform provides pathologists and researchers with actionable insights.

The company aims to drive innovation at the intersection of technology and healthcare, enhancing its market position with the new investment.

Comments